Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Ethnopharmacological relevance</h3><p>The alcoholic liver injury (ALI) commonly occurs among people, typically the young and the middle-aged, who drink heavily. The ALI is extremely harmful and can induce severe disease states such as hepatitis, liver fibrosis, cirrhosis or even liver cancer. Recent studies found that the pathological changes of hepatocytes and hepatic stellate cell showed significant connection between endoplasmic reticulum (ER) stress which is the key factor to aggravate the development of liver pathology in patients with ALI. However, the detailed mechanism needs to be further studied. <em>Schisandra chinensis</em>, a member of TCM, has been used as a Chinese folk medicine for treatments of chronic or acute diseases especially the liver diseases, and especially <em>Schisandra chinensis</em> (<em>S. chinensis</em>) derived lignans (SCDLs) have been shown to alleviate liver pathological changes.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aim of the study</h3><p>This study sought to elucidate the mechanisms underlying SCDLs-mediated hepatoprotection.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3><p>We first used <em>in silico</em> target prediction and computational simulation methods to identify putative lignans binding targets relative to the hepatoprotective effect. The gene microarray analysis was also performed in this study to identify differently expressed genes which may have significance in disease pathological process; we then used histological analyses in a mice hepatotoxicity model to test the effectiveness of SCDLs in vivo, and hepatocellular toxicity model to analyze the candidate compound mediated hepatoprotection and expression states of the key targets in vitro.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p><em>In silico</em> analysis results showed endothelin receptor B (ETBR/EDNRB) is likely a significant node during the liver pathological change process and a promising key target for the SCDLs compound Schisantherin D on the hepatoprotective effect; experimental studies showed that Schisantherin D alleviated HL-7702 cell (belongs to liver parenchymal cell lines) injury ratio, decreased expression of ETBR, and inhibited ECMs and ET-1 secretion in LX-2 cells (one form of hepatic stellate cells); SCDLs ameliorated the fibrosis formation in mice liver tissue. Liver tissue western blots of SCDLs treated mice showed down-regulated α-SMA, ETBR, PLCβ, CHOP, Bax, and the apoptotic factors of cleaved-caspase 12, cleaved-caspase 9 and cleaved-caspase 3 indicating the anti-apoptosis and hepatoprotective effect. SCDLs treatment also elevated serum glutathione (GSH) and reduced serum transforming growth factor-β1 (TGF-β1) level.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>SCDLs appears to prevent hepatotoxicity by the anti-fibrotic, anti-oxidance, and anti-apoptosis properties. ETBR may be the key factor in EtOH induced long term liver degeneration.</p>

Schisandrol A, a bioactive constituent from Schisandrae Chinensis Fructus, alleviates drug-induced liver injury by autophagy activation via exosomes

A network pharmacology-integrated metabolomics strategy for clarifying the action mechanisms of Schisandrae Chinensis Fructus for treating drug-induced liver injury by acetaminophen

Schisantherin D from Schisandra chinensis (Turcz.) Baill. exhibits anti-liver fibrosis capacity via modulating ETBR involved signaling, an in vitro and in vivo study

Schisandrin B ameliorates acute liver injury by regulating EGFR-mediated activation of autophagy

Ameliorative effect of Schisandrol B against Diosbulbin B-induced hepatotoxicity via inhibiting CYP3A4-mediated bioactivation

The protective effects of aqueous extract of Schisandra sphenanthera against alcoholic liver disease partly through the PI3K-AKT-IKK signaling pathway

Integrated Plasma and Bile Metabolomics Based on an UHPLC-Q/TOF-MS and Network Pharmacology Approach to Explore the Potential Mechanism of Schisandra chinensis-Protection From Acute Alcoholic Liver Injury

<i>Schisandra chinensis</i> essential oil attenuates acetaminophen-induced liver injury through alleviating oxidative stress and activating autophagy

Anwulignan Alleviates the Acute Liver Injury Induced by Acetaminophen in Mice

Schisandrin B Ameliorated Chondrocytes Inflammation and Osteoarthritis Via Suppression of NF-κB and MAPK Signal Pathways.

Schisandrol A, the main active ingredient of Schisandrae Chinensis Fructus, inhibits pulmonary fibrosis through suppression of the TGF-β signaling pathway as revealed by UPLC-Q-TOF/MS, network pharmacology and experimental verification

The regulation of GSH/GPX4-mediated lipid accumulation confirms that schisandra polysaccharides should be valued equally as lignans

Schisandrin B targets cannabinoid 2 receptor in Kupffer cell to ameliorate CCl4-induced liver fibrosis by suppressing NF-κB and p38 MAPK pathway

Lignans from Schisandra chinensis ameliorate alcohol and CCl4-induced long-term liver injury and reduce hepatocellular degeneration via blocking ETBR

Therapeutic efficacy of Wuzhi tablet (Schisandra sphenanthera Extract) on acetaminophen-induced hepatotoxicity through a mechanism distinct from N-acetylcysteine

Smilax china L. Polysaccharide Alleviates Oxidative Stress and Protects From Acetaminophen-Induced Hepatotoxicity via Activating the Nrf2-ARE Pathway

Schisandrin A alleviates mycophenolic acid-induced intestinal toxicity by regulating cell apoptosis and oxidative damage

Schisandrin B regulates macrophage polarization and alleviates liver fibrosis via activation of PPARγ

Metabolomics Profiling in a Mouse Model Reveals Protective Effect of Sancao Granule on Con A-Induced Liver Injury.

Synergistic Hepatoprotective Effect of Schisandrae Lignans with Astragalus Polysaccharides on Chronic Liver Injury in Rats

Schizandrin C regulates lipid metabolism and inflammation in liver fibrosis by NF-κB and p38/ERK MAPK signaling pathways